Maitane Nunez-Garcia
Overview
Explore the profile of Maitane Nunez-Garcia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
10
Citations
146
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Lorenzo P, Izquierdo A, Sajoux I, Nunez-Garcia M, Gomez-Arbelaez D, Zulet M, et al.
Clin Nutr
. 2025 Feb;
47:40-49.
PMID: 39986176
Background & Aim: Osteopontin (OPN) was proposed to play a role in the pathophysiology of obesity and related disease, such as cancer. The aims were to evaluate the expression of...
2.
Correa L, Medeiros de Sousa P, Dinis L, Carloto L, Nunez-Garcia M, Sajoux I, et al.
Endocrinol Diabetes Metab Case Rep
. 2022 Sep;
2022.
PMID: 36094136
Summary: There is a close association between obesity and type 2 diabetes (T2D). The value of weight loss in the management of patients with T2D has long been known. Loss...
3.
Sanchez E, Santos M, Nunez-Garcia M, Bueno M, Sajoux I, Yeramian A, et al.
Nutrients
. 2022 Jan;
14(1).
PMID: 35010908
Weight loss after bariatric surgery decreases the earlier expansion of the adventitial vasa vasorum (VV), a biomarker of early atheromatous disease. However, no data are available regarding weight loss achieved...
4.
Correa L, Moretti A, Medeiros de Sousa P, Dinis L, de Souza M, Tostes I, et al.
Obes Surg
. 2021 Sep;
31(12):5383-5390.
PMID: 34558025
Purpose: Obesity is one of the major public health problems worldwide and bariatric surgery is considered the gold standard treatment for severe obesity. Although the literature supports the safety and...
5.
Gonzalez-Romero F, Mestre D, Aurrekoetxea I, ORourke C, Andersen J, Woodhoo A, et al.
Cancer Res
. 2021 Mar;
81(11):2874-2887.
PMID: 33771899
Lipid metabolism rearrangements in nonalcoholic fatty liver disease (NAFLD) contribute to disease progression. NAFLD has emerged as a major risk for hepatocellular carcinoma (HCC), where metabolic reprogramming is a hallmark....
6.
Gomez-Santos B, Saenz de Urturi D, Nunez-Garcia M, Gonzalez-Romero F, Buque X, Aurrekoetxea I, et al.
Aging Cell
. 2020 Jul;
19(8):e13183.
PMID: 32638492
Osteopontin (OPN), a senescence-associated secretory phenotype factor, is increased in patients with nonalcoholic fatty liver disease (NAFLD). Cellular senescence has been associated with age-dependent hepatosteatosis. Thus, we investigated the role...
7.
Simon J, Nunez-Garcia M, Fernandez-Tussy P, Barbier-Torres L, Fernandez-Ramos D, Gomez-Santos B, et al.
Cell Metab
. 2020 Feb;
31(3):605-622.e10.
PMID: 32084378
Non-alcoholic steatohepatitis (NASH) is characterized by the accumulation of hepatic fat in an inflammatory/fibrotic background. Herein, we show that the hepatic high-activity glutaminase 1 isoform (GLS1) is overexpressed in NASH....
8.
Fernandez-Tussy P, Fernandez-Ramos D, Lopitz-Otsoa F, Simon J, Barbier-Torres L, Gomez-Santos B, et al.
Mol Metab
. 2019 Nov;
29:40-54.
PMID: 31668391
Objective: Non-alcoholic fatty liver disease (NAFLD) is a complex pathology in which several dysfunctions, including alterations in metabolic pathways, mitochondrial functionality and unbalanced lipid import/export, lead to lipid accumulation and...
9.
Nunez-Garcia M, Gomez-Santos B, Saenz de Urturi D, Mestre D, Gonzalez-Romero F, Buque X, et al.
Sci Rep
. 2018 Oct;
8(1):14626.
PMID: 30279550
Osteopontin (OPN), a multifunctional cytokine that controls liver glycerolipid metabolism, is involved in activation and proliferation of several liver cell types during regeneration, a condition of high metabolic demands. Here...
10.
Nunez-Garcia M, Gomez-Santos B, Buque X, Garcia-Rodriguez J, Romero M, Marin J, et al.
J Lipid Res
. 2017 Jul;
58(9):1903-1915.
PMID: 28754826
Osteopontin (OPN) is involved in different liver pathologies in which metabolic dysregulation is a hallmark. Here, we investigated whether OPN could alter liver, and more specifically hepatocyte, lipid metabolism and...